Purchases and Sales Made in Q2 2025 in Elevation Oncology, Inc. (ELEV)
This table provides information about the institutional ownership of Elevation Oncology, Inc. (ELEV) during Q2 2025. The information is specifically focused on institutions that hold shares of Elevation Oncology, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 12, 2025
Q2 2025
|
Nuveen, LLC
Charlotte, NC |
SELL
|
- |
-150K- 86.27% |
$34.6K - $58.6K
|
23.9K
$8.61K
|
|
Aug 11, 2025
Q2 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-329K- 12.71% |
$75.6K - $128K
|
2.26M
$812K
|
|
Aug 14, 2025
Q2 2025
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-362K- 82.54% |
$83.2K - $141K
|
76.5K
$27.5K
|
|
Aug 13, 2025
Q2 2025
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-368K- 80.17% |
$84.5K - $143K
|
90.9K
$32.7K
|
|
Aug 13, 2025
Q2 2025
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-481K- 74.38% |
$111K - $188K
|
166K
$59.7K
|
|
Aug 08, 2025
Q2 2025
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-648K- 54.59% |
$149K - $253K
|
539K
$194K
|
|
Aug 14, 2025
Q2 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-862K- 81.56% |
$198K - $336K
|
195K
$70.1K
|